Hepatoprotective activity of Taiwan folk medicine: Eclipta prostrata Linn. against various hepatotoxins induced acute hepatotoxicity

Phytotherapy Research

Volumn 10, Issue 6, 1996, Pages 483-490

  Lin, Song Chow ^a   Yao, Chih Jung ^a   Lin, Chun Ching ^b   Lin, Yun Ho ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

D galactosamine; acetaminophen; carbon tetrachloride; Eclipta prostrata; hepatoprotective effects

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; ECLIPTA PROSTRATA EXTRACT; GALACTOSAMINE; LIVER PROTECTIVE AGENT; PARACETAMOL; PLANT EXTRACT;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; RAT; SEROLOGY; TAIWAN; TRADITIONAL MEDICINE;

ECLIPTA PROSTRATA;

EID: 0029804376     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199609)10:6<483::AID-PTR884>3.0.CO;2-2     Document Type: Article

References (47)

1. Abe, H., Sakaguchi, M., Anno, M., and Arichi, S. (1981). Erythrocyte membrane stabilization by plant saponins and sapogenins. Naunyn-Schmiedberg's Arch. Pharmacol. 316, 262-265.
2. Anukarahanonta, T., Shinozuka, H., and Farber, E. (1973). Inhibition of protein synthesis in rat liver by D-galactosamine. Res. Commun. Chem. Path. Pharm. 5, 481-491.
3. Bergmeyer, H. U., Scheibe, P., and Wahlefeld, A. W. (1978). Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem. 24, 58.
4. Bhathal, P. S., Rose, N. R., Mackay, I. R., and Whittingham, S. (1983). Strain differences in mice in carbon tetrachloride-induced liver injury. Br. J. Exp. Pathol. 64, 524-533.
5. Black, M. (1984). Acetaminophen hepatotoxicity. Annu. Rev. Med. 35, 577.
6. Castro, J. A., Ferreyra, E. C., de Castro, C. R. et al. (1977). Studies on the role of protein synthesis in cell injury by toxic agents. I. Effect of cycloheximide administration on several factors modulating carbon tetrachloride induced liver necrosis. Toxicol. Appl. Pharmacol. 41, 305.
7. Chiba, T., Horiuchi, M., and Koike, F. (1979). Effect of thiol compounds on experimental liver damage (IV). Detoxicating effect of tiopronin, glutathione and cystein on ethionine induced liver damage. Folia Pharmacol. Japon. 75, 645-654.
8. Chiu, H. F., Lin, C. C., Yang, C. C., and Yang, F. (1988). The pharmacological and pathological studies on several hepatic protective crude drugs from Taiwan (I). Am. J. Chin. Med. 16, 127-137.
9. Chiu, H. F., Lin, C. C., Yang, C. C., and Yang, F. (1989). The pharmacological and pathological studies on several hepatic protective crude drugs from Taiwan (II). Am. J. Chin. Med. 17, 17-23.
10. Cullen, J. M., and Ruebner, B. H. (1991). A histologic classification of chemical-induced injury of the liver. In, Hepatotoxicology, ed. by R. G. Meeks, S. D. Harrison and R. J. Bull, pp. 68, CRC Press Inc., N.W., Boca Raton, Florida.
11. Dahlin, D. C., Miwa, G. T., Lu, A. Y. H., and Nelson, S. D. (1984). N-acetyl-p-benzoquinone imine: A cytochrome P-450-dependent oxidation product of acetaminophen. Proc. Natl Acad. Sci. 81, 1327-1331.
12. Decker, K., Keppler, D., Rudigier, J., and Domschke, W. (1971). Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. Hoppe Seylers 2. Physiol. Chem. 352, 412-418.
13. De Ferreyra, E. C., de Fenos, O. M., and Castro, J. A. (1985). Late preventive effects of several anticalmodulin drugs on galactosamine-induced liver necrosis. Res. Commun. Chem. Path. Pharm. 47, 289-292.
14. Dumont, J. M., Maignan, M. F., and Perrissoud, D. (1987). Protective effect of malotilate against galactosamine intoxication in the rat. Arch. Int. Pharmacodyn. Ther. 289, 269-310.
15. Farber, J. L. (1979). Reactions of the liver to injury. In, Toxic Injury of the Liver, ed. by E. Farber and M. Fisher, pp. 215-241, Marcel Dekker Inc., New York and Basel.
16. Gilette, J. R. (1975). Mechanism of hepatic necrosis induced by halogenated aromatic hydrocarbons. In, Pathogenesis and Mechanisms of Liver Cell Necrosis, ed. by D. Keppler pp. 239-544, Lancaster MTP Press Ltd., St. Leonard House, Lancaster UK.
17. Gruen, M., Liehr, H., Gruen, W., Rasenack, U., and Branswig, D. (1974). Influence of liver-RES (reticulo-endothelial-system) on toxic liver damage due to galactosamine. Acta Hepato-Gastroenterol. 21, 5.
18. Hatta, S., Suzuki, T., Miyamoto, A., Takemura, H., and Ohshika, H. (1986). Effects of 8-(2-dimethylaminoethyl)-3-oxo-4-phenyl-1-thia-4,8-diazaspiro- [4,5] decane dihydrochloride monohydrate (Y-8845) on carbon tetrachloride-induced liver injury. Jpn. J. Pharmacol. 40, 561-567.
19. Hendrina Van Vugt, Jacobus Van Gool, and Lambert, L. M. T. (1983). Galactosamine hepatitis, endotoxemia, and lactulose. Hepatology 3, 241-247.
20. Hinson, J. A. (1980). Biochemical toxicology of acetaminophen. Rev. Biochem. Toxicol. 2, 103-129.
21. Hinson, J. A., Monks, T. J., Hong, M., Highet, R. J., and Pohl, L. R. (1982). 3-(Glutathion-S-yl)acetaminophen: A biliary metabolite of acetaminophen. Drug. Metab. Dispos. 10, 47-50.
22. Hirooa, S., Tanaka, T., Nogata, M., Katoh, M., and Sugimoto, T. (1982). Effect of malotilate on hepatic injury induced by D-galactosamine in rat. lyakuhin Kenkyu 13, 1046-1052.
23. Hoffmann, K. J., Streeter, A. J., Axworth, D. B., and Baillie, T. A. (1985). Structural characterization of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Mol. Pharmacol. 27, 566-573.
24. Imaizumi, Y., Katoh, M., and Sugimoto, T. (1982). Effects of malotilate on the synthesis and movement of RNA in rat's liver. Folia Pharmacol. Japon. 79, 285-291.
25. Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973). Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187, 195-202.
26. Katoh, M., Kitada, M., Satoh, T., Kitagawa, H., Sugimoto, T., and Kasai, T. (1981). Further studies on the in vivo effect of diisopropyl 1,3-dithiol-2-ylidene malonate (NKK-105) on the liver microsomal drug oxidation system in rats. Biochem. Pharmacol. 30, 2759-2765.
27. Keppler, D., and Decker, K. (1969). Studies on the mechanism of galactosamine hepatitis: Accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Fur. J. Biochem. 10, 219-225.
28. Keppler, D. O. R., Rudigier, J. F. M., Bischoff, E., and Decker, F. F. A. (1970). The trapping of uridine phosphates by D-galactosamine, D-glucosamine, and 2-deoxy-D-galactose. A study on the mechanism of galactosamine hepatitis. Eur. J. Biochem. 17, 246-253.
29. 4 in rats: Histochemical, enzyme-histochemical and ultrastructural studies. Folia Pharmacol. Japon. 93, 17-27.
30. Lesh, R., Reutter, W., Keppler, D., and Decker, K. (1970). Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats. Exp. Mol. Pathol. 12, 58.
31. Lin, C. C., Chiu, H. F., Yen, M. H., Wu, C. C., and Chen, M. F. (1990a). The pharmacological and pathological studies on Taiwan folk-medicine (III). The effects of Bupleurum kaoi and cultivated Bupleurum falcatum var, kamarowi. Am. J. Chin. Med. 18, 105-112.
32. Lin, C. C., Yen, M. H., Chiu, H. F., and Chang, C. H. (1990b). The pharmacological and pathological studies on Taiwan folk-medicine (IV) - The effects of Echinops grijisii and E. latifolius. Am. J. Chin. Med. 18, 113-120.
33. Mitchell, J. R. (1988). Acetaminophen toxicity. N. Engl. J. Med. 319, 1601-1602.
34. Mitchell, J. R. and Jollow, D. J. (1975). Metabolic activation of drugs toxic substances. Gastroenterology 68, 392-410.
35. Mitchell, J. R., Potter, W. Z., Hinson, J. A., Snodgrass, W. R., Timbrell, J. A., and Gillette, J. R. (1975). Toxic drug reactions. In, Handbook of Experimental Pharmacology, ed. by O. Eichler, A. Farah, H. Hecken, A. D. Welch, pp. 382-419, New Series, Springer-Verlag, Berlin.
36. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973a). Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187, 185-194.
37. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., and Brodie, B. B. (1973b). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187, 211-217.
38. 4-induced acute or chronic liver injury in rats. Folia Pharmacol. Japon. 94, 137-144.
39. Potter, D. W., and Hinson, J. A. (1986). Reactions of N-acetyl-p-benzoquinone-imine with reduced glutathione, acetaminophen, and NADPH. Mol. Pharmacol. 30, 33-41.
40. Recknagel, R. O., and Ghoshal, A. K. (1966). Lipoperoxidation as a vector in carbon tetrachloride hepatotoxicity. Lab. Invest. 15, 132.
41. Reutter, W., Hassels, B., and Lesch, R. (1975). Induction and prevention of galactosamine hepatitis. In, New Trends in the Therapy of Liver Diseases, ed. by A. Bertelli, pp. 121, S. Karger, Basel.
42. Reynolds, E. S. (1977). Liver endoplasmic reticulum. Target site of halocarbon metabolites. Adv. Exp. Med. Biol. 84, 1171-137.
43. Reynolds, E. S., and Moslen, M. T. (1979). Environmental liver injury: halogenated hydrocarbons. In, Toxic Injury of the Liver, ed. by E. Farber and M. Fisher pp. 591-596, Marcel Dekker Inc., New York and Basel.
44. Reynolds, E. S., and Ree, H. J. (1971). Liver parenchymal cell injury. VII. Membrane denaturation following carbon tetrachloride. Lab. Invest. 25, 269-278.
45. Shoji, S., Isao, K., Rumiko, T., and Haruhiro, F. (1966). The chemical studies on oriental plant drugs. X IV. The constituents of Bupleurum spp. (1) Yakugaku Zasshi. 86, 1132-1137.
46. Slater, T. F. (1966). Necrogenetic action of carbon tetrachloride in the rat: A speculative mechanism based on activation. Nature 209, 36-40.
47. Zieve, L., Anderson, W. R., and Dozeman, R. (1988). Hepatic regenerative enzyme activity after diffuse injury with galactosamine: Relationship to histologic alterations. J. Lab. Clin. Med. 112, 575-582.